| |
| |
|
| Insider
Information: |
Ajer Jeffrey Robert |
| Relationship: |
Director |
| City: |
Novato |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
105,620 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$6,387,740 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
105,620 |
|
|
| Total
Value |
$6,387,740 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
3
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -20.4%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Biomarin Pharmaceutical Inc |
BMRN |
EVP, Chief Commercial ... |
2024-03-15 |
71,467 |
|
0 |
Premium* |
|
|
Nektar Therapeutics |
NKTR |
Director |
2023-09-18 |
34,153 |
2017-09-19 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
172 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 7
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NKTR |
Nektar Therapeutics |
Director |
– • – |
2017-09-19 |
4 |
A |
$0.00 |
$0 |
D/D |
22,500 |
22,500 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
Director |
– • – |
2018-09-20 |
4 |
AS |
$56.76 |
$383,130 |
D/D |
(6,750) |
15,750 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
Director |
– • – |
2018-09-27 |
4 |
A |
$0.00 |
$0 |
D/D |
4,750 |
20,500 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
Director |
– • – |
2019-09-20 |
4 |
AS |
$20.24 |
$45,540 |
D/D |
(2,250) |
18,250 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
Director |
– • – |
2019-09-25 |
4 |
A |
$0.00 |
$0 |
D/D |
6,500 |
24,750 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
Director |
– • – |
2019-09-30 |
4 |
AS |
$18.06 |
$42,893 |
D/D |
(2,375) |
22,375 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
Director |
– • – |
2020-09-21 |
4 |
AS |
$19.74 |
$44,415 |
D/D |
(2,250) |
20,125 |
0 |
% |
|
| NKTR |
Nektar Therapeutics |
Director |
– • – |
2020-09-22 |
4 |
A |
$0.00 |
$0 |
D/D |
9,100 |
29,225 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
Director |
– • – |
2020-09-28 |
4 |
AS |
$17.25 |
$56,063 |
D/D |
(3,250) |
25,975 |
0 |
% |
|
| NKTR |
Nektar Therapeutics |
Director |
– • – |
2021-09-22 |
4 |
S |
$17.78 |
$65,164 |
D/D |
(3,665) |
32,510 |
0 |
% |
|
| NKTR |
Nektar Therapeutics |
Director |
– • – |
2021-09-22 |
4 |
A |
$0.00 |
$0 |
D/D |
10,200 |
36,175 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
Director |
– • – |
2022-09-16 |
4 |
A |
$0.00 |
$0 |
D/D |
10,200 |
42,710 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
Director |
– • – |
2022-09-23 |
4 |
S |
$3.16 |
$13,266 |
D/D |
(4,198) |
38,512 |
0 |
% |
|
| NKTR |
Nektar Therapeutics |
Director |
– • – |
2023-09-18 |
4 |
S |
$0.69 |
$3,008 |
D/D |
(4,359) |
34,153 |
0 |
% |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2016-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
16,190 |
63,072 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2016-04-29 |
4 |
A |
$51.26 |
$21,275 |
D/D |
415 |
63,487 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2016-05-03 |
4 |
AS |
$86.03 |
$35,701 |
D/D |
(415) |
63,072 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2016-05-06 |
4 |
D |
$80.80 |
$54,863 |
D/D |
(679) |
62,393 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2016-05-13 |
4 |
D |
$82.71 |
$90,650 |
D/D |
(1,096) |
61,297 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2016-06-03 |
4 |
D |
$90.00 |
$133,920 |
D/D |
(1,488) |
59,809 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2016-09-27 |
4 |
AS |
$95.61 |
$1,765,648 |
D/D |
(18,467) |
41,342 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2017-02-24 |
4 |
A |
$95.61 |
$1,139,396 |
D/D |
11,917 |
53,259 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2017-03-03 |
4 |
D |
$93.95 |
$164,319 |
D/D |
(1,749) |
51,510 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2017-03-07 |
4 |
AS |
$90.56 |
$452,800 |
D/D |
(5,000) |
46,510 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2017-03-15 |
4 |
D |
$92.50 |
$304,140 |
D/D |
(3,288) |
43,222 |
0 |
- |
|
172 Records found
|
|
Page 1 of 7 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
